Back
Petros Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
PTPI
Sponsored
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
37
PTPI
Petros Pharmaceuticals
Last Price:
0.35
Seasonality Move:
8.08%
7 Day Trial
ALL ACCESS PASS
$
7
Supercharge Your Portfolio with This High-Traction AI Startup
Learn MorePetros Pharmaceuticals Price Quote
$0.35
-0.01 (-2.78%)
(Updated: October 5, 2024 at 6:47 AM ET)
Petros Pharmaceuticals Key Stats
Sell
37
Petros Pharmaceuticals (PTPI)
is a Sell
Day range:
$0.35 - $0.36
52-week range:
$0.28 - $2.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.36
P/B ratio:
0.42%
Volume:
39.4K
Avg. volume:
78.3K
1-year change:
-77.1%
Market cap:
$3.4M
Revenue:
$5.8M
EPS:
$-6.54
How Much Does Petros Pharmaceuticals Make?
-
How Much Are Petros Pharmaceuticals's Sales Annually?
PTPI Revenues are $5.8M -
How Much Profit Does Petros Pharmaceuticals's Make A Year?
PTPI net income is -$8.2M
Is Petros Pharmaceuticals Growing As A Company?
-
What Is Petros Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.29% -
What Is Petros Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Petros Pharmaceuticals Stock Price Performance
-
Did Petros Pharmaceuticals Stock Go Up Last Month?
Petros Pharmaceuticals share price went up by 5.97% last month -
Did PTPI's Share Price Rise Over The Last Year?
PTPI share price fell by -77.1% over the past 1 year
What Is Petros Pharmaceuticals 52-Week High & Low?
-
What Is Petros Pharmaceuticals’s 52-Week High Share Price?
Petros Pharmaceuticals has traded as high as $2.27 over the past 52 weeks -
What Is Petros Pharmaceuticals’s 52-Week Low Share Price?
Petros Pharmaceuticals has traded as low as $0.28 over the past 52 weeks
Petros Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Petros Pharmaceuticals?
-
How Much Debt Does Petros Pharmaceuticals Have?
Total long term debt quarterly is $7.6M -
How Much Cash Does Petros Pharmaceuticals Have?
Cash and short term investments quarterly total is $7.5M -
What Is Petros Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.87
Is Petros Pharmaceuticals Cash Flow Positive?
-
What Is PTPI Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.1M -
What Is Petros Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $9.2M -
What Is Petros Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Petros Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
PTPI return on invested capital is -37.87% -
What Is Petros Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -22.48% -
What Is PTPI Return On Equity?
ROE is a measure of profitability and is -67.38%
Petros Pharmaceuticals Earnings Date & Stock Price
-
What Is Petros Pharmaceuticals's Stock Price Today?
A single share of PTPI can be purchased today for 0.36 -
What Is Petros Pharmaceuticals’s Stock Symbol?
Petros Pharmaceuticals trades on the nasdaq under the ticker symbol: PTPI -
When Is Petros Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Petros Pharmaceuticals is scheduled on October 5, 2024 -
When Is PTPI's next ex-dividend date?
Petros Pharmaceuticals's next ex-dividend date is October 5, 2024 -
How To Buy Petros Pharmaceuticals Stock?
You can buy Petros Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Petros Pharmaceuticals Competitors
-
Who Are Petros Pharmaceuticals's Competitors?
Below is a list of companies who compete with Petros Pharmaceuticals or are related in some way:
Petros Pharmaceuticals Dividend Yield
-
What Is PTPI Dividend Yield?
Petros Pharmaceuticals’s dividend yield currently is 0% -
What Is Petros Pharmaceuticals’s Payout Ratio?
Petros Pharmaceuticals’s payout ratio is 0% -
When Did Petros Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 5, 2024 -
What Is Petros Pharmaceuticals’s Dividend Per Share?
Petros Pharmaceuticals pays a dividend of $0.00 per share
Petros Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 51.95% |
Revenue: | -28.71% | 1.75% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 1.00 |
Upside from Last Price: | 181.69% |